Section 32
Signal active
Investment Firm
Overview
Section 32, the new venture fund launched by Bill Maris, was named in homage to Section 31, an intelligence agency from the Star Trek universe.
Maris, the GV (Google Ventures) founder/former-CEO, has raised $150 million for the project that will focus on various investments.
The fund will be run directly by Maris and primarily based out of San Diego.
Highlights
Founded
2017
Industry
Financial Services
Employees
11-50
Investment
120
Lead Investment
26
Exits
21
Stages
Late Stage Venture, Seed, Early Stage Venture
Investor Type
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Section 32, established in 2017 and headquartered in United States, North America., specializes in Late Stage Venture, Seed, Early Stage Venture investments across Information Technology, Music, Marketing, Independent Music, Music Label, Financial Services, Venture Capital, Finance, Service Industry, Publishing. The organization boasts a portfolio of 118 investments, with an average round size of $80.2M and 21 successful exits. Their recent investments include Kobalt, Balderton Capital, MSD Capital, Hearst Entertainment, BloomAPI. The highest investment round they participated in was $1165.7B. Among their most notable exits are Kobalt and Balderton Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Section 32 has made 120 investments. Their most recent investment was on Jul 24, 2024, when Autobahn Therapeutics raised $100.0M.
Section 32 has made 36 diversity investments. Their most recent diversity investment was on Sep 12, 2023, when ROME Therapeutics raised $72.0M.
investments
120
Diversity investments
36
Lead investments
26
Number of exits
21
Investments
120
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Mar 05, 2024 | Ema | Software | 25.0M |
| Mar 26, 2024 | - | - | 33.0M |
| Jul 08, 2024 | - | - | 28.0M |
| Jul 24, 2024 | Autobahn Therapeutics | Biotechnology | 100.0M |
Exits
21
Funding Timeline
Funding rounds
120
Investors
0
Funds
5
Funding Rounds
120
Section 32 has raised 120 rounds. Their latest funding was raised on Jul 24, 2024 from a Series C - Autobahn Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Mar 05, 2024 | Seed Round - Ema | - | 25.0M | - |
| Mar 26, 2024 | Series C - Brightside Health | - | 33.0M | - |
| Jul 08, 2024 | Seed Round - Sola Security | - | 28.0M | - |
| Jul 24, 2024 | Series C - Autobahn Therapeutics | - | 100.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.